1.The Clinical Outcomes of Proton Beam Radiation Therapy for Retinoblastomas That Were Resistant to Chemotherapy and Focal Treatment.
Ji Woong CHANG ; Young Suk YU ; Joo Young KIM ; Dong Ho SHIN ; Jin CHOI ; Jeong Hun KIM ; Seong Joon KIM
Korean Journal of Ophthalmology 2011;25(6):387-393
PURPOSE: To evaluate the clinical results of proton beam radiation therapy (PBRT) for treatment of retinoblastoma. METHODS: Children with retinoblastoma who were treated with chemotherapy and focal treatment such as brachytherapy and thermotherapy but showed no response or developed recurrences later received PBRT. The PBRT strategy was designed to concentrate the radiation energy to the retinoblastoma and spare the surrounding healthy tissue or organs. RESULTS: There were three patients who received PBRT. The first patient received PBRT because of an initial lack of tumor regression with chemotherapy and brachytherapy. This patient showed regression after PBRT. The second patient who developed recurrence of retinoblastoma as diffuse infiltrating subretinal seeding was taken PBRT. After complete regression, there was recurrence of tumor and the eye was enucleated. The third patient had unilateral extensively advanced retinoblastoma. Initial chemotherapy failed and tumor recurred. The tumor responded to PBRT and regressed significantly. However, the eye developed sudden multiple recurrences, so we had to perform enucleation. CONCLUSIONS: PBRT for retinoblastoma was effective in cases of showing no response to other treatment modalities. However, it should be carefully applied when there was recurrence of diffuse infiltrating subretinal seeding or extensively advanced retinoblastoma initially.
Child, Preschool
;
Combined Modality Therapy
;
Drug Resistance
;
Female
;
Humans
;
Infant
;
Male
;
Retinal Neoplasms/drug therapy/*radiotherapy/surgery
;
Retinoblastoma/drug therapy/*radiotherapy/surgery
;
Retrospective Studies
;
Treatment Outcome
2.A Case of Radiation Retinopathy of Left Eye After Radiation Therapy of Right Brain Metastasis.
Kwon Ho HONG ; Sung Dong CHANG
Korean Journal of Ophthalmology 2009;23(2):114-117
A 37-year-old female, who had received modified radical mastectomy for cancer of her right breast, presented with decreased visual acuity in the left eye after radiation therapy for the management of the metastasis to her right brain 14 months ago. After ocular examination, we diagnosed her as radiation retinopathy. At the time of the first visit, the corrected best visual acuity was 0.4 in the left eye, and fundus examination revealed cotton wool spots and cystoid macular edema (CME). The findings in the right eye were normal except for cotton wool spots in the superior major arch. Fluorescein angiography (FA) showed marked telangiectasia and microaneurysms in her left eye but tiny microaneurysms in her right eye. Subsequent optical coherent tomography (OCT) showed CME. We injected intravitreal triamcinolone acetonide (TA). Two weeks after treatment, the visual acuity was improved to 0.6 and the retinal thickness was decreased. Three months later, the visual acuity in the left eye was dropped to 0.3 due to the recurrence of CME, so we injected intravitreal TA again. Five months later, visual acuity was improved to 0.5 and OCT revealed the improvement of CME. The incidence of radiation retinopathy is higher in the side nearer to radiation, but careful radiation blocking is also required on the opposite side of irradiation site considering the possibility of radiation retinopathy and careful observation is required on both sides of the eyes when performing fundus examination.
Adult
;
Brain Neoplasms/*radiotherapy/secondary
;
Breast Neoplasms/pathology/radiotherapy/surgery
;
Diagnosis, Differential
;
Female
;
Fluorescein Angiography
;
Follow-Up Studies
;
Fundus Oculi
;
Glucocorticoids/administration & dosage
;
Humans
;
Radiation Injuries/diagnosis/drug therapy/*etiology
;
Retina/pathology/*radiation effects
;
Retinal Diseases/diagnosis/drug therapy/*etiology
;
Tomography, Optical Coherence
;
Triamcinolone Acetonide/administration & dosage